MYBL2, GNG10, and AHNAK2 exhibited an elevated gene expression in recurrent gliomas, suggesting involvement in cancer progression (e.g., MYBL2 p = 5.5 × 10−6). Here, AHNAK2 is linked to central nervous system cancer.